RedHill Biopharma Ltd. (RDHL) Institutional Ownership Changes & 13F Activity
RedHill Biopharma Ltd. (RDHL). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q4 2025). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Yorkville Advisors Global, Lp, Gagnon Securities Llc, Citadel Advisors Llc, Gamma Investing Llc, and Federation Des Caisses Desjardins Du Quebec.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Danske Bank A/S | Sell | -2 | -100.0% | 0 | $0.00 | Q4 2025 | Mar 18, 2026 |
| Garton & Associates Financial Advisors Llc | Buy | +15 | — | 15 | $15.00 | Q4 2025 | Feb 18, 2026 |
| Citadel Advisors Llc | Buy | +15,477 | — | 15,477 | $15.94K | Q4 2025 | Feb 17, 2026 |
| Bank Of America Corp | Buy | +303 | — | 303 | $312.00 | Q4 2025 | Feb 17, 2026 |
| Royal Bank Of Canada | Buy | +1 | — | 1 | $0.00 | Q4 2025 | Feb 17, 2026 |
| Gagnon Securities Llc | Buy | +86,102 | — | 86,102 | $88.69K | Q4 2025 | Feb 13, 2026 |
| Rhumbline Advisers | Buy | +2,678 | — | 2,678 | $2.75K | Q4 2025 | Feb 13, 2026 |
| Smartleaf Asset Management Llc | Buy | +5 | — | 5 | $5.00 | Q4 2025 | Feb 13, 2026 |
| Morgan Stanley | Buy | +1 | — | 1 | $1.00 | Q4 2025 | Feb 13, 2026 |
| Federation Des Caisses Desjardins Du Quebec | Buy | +3,388 | — | 3,388 | $3.49K | Q4 2025 | Feb 12, 2026 |
| Group One Trading Llc | Buy | +4 | — | 4 | $4.00 | Q4 2025 | Feb 12, 2026 |
| Vermillion Wealth Management, Inc. | Buy | +2 | — | 2 | $2.00 | Q4 2025 | Feb 11, 2026 |
| Yorkville Advisors Global, Lp | Buy | +386,593 | — | 386,593 | $398.19K | Q4 2025 | Feb 10, 2026 |
| Eversource Wealth Advisors, Llc | Buy | +38 | — | 38 | $39.00 | Q4 2025 | Feb 06, 2026 |
| Sbi Securities Co., Ltd. | Buy | +4 | — | 4 | $4.00 | Q4 2025 | Feb 03, 2026 |
| Your Advocates Ltd., Llp | Buy | +19 | — | 19 | $20.00 | Q4 2025 | Feb 02, 2026 |
| Ubs Group Ag | Buy | +18 | — | 18 | $18.00 | Q4 2025 | Jan 29, 2026 |
| Gamma Investing Llc | Buy | +4,828 | — | 4,828 | $4.97K | Q4 2025 | Jan 05, 2026 |
Frequently asked questions about RDHL activity
Which institutional owners are buying RDHL?
Institutional owners buying RDHL include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in RDHL activity?
"Buy" means an investor increased their reported position in RDHL compared to the prior reporting period. This reflects growing exposure to RedHill Biopharma Ltd. (RDHL) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in RDHL increasing?
Institutional interest in RDHL can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related RDHL Institutional Insights
- RDHL Overview
- RDHL 13F Institutional Holders
- RDHL Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- RDHL Insider Trading & SEC Form 4 Activity
- RDHL Articles
- Top Institutional Investor Stock Rankings